Photo of Shih-Jiuan Chiu

View Scopus Profile

Shih-Jiuan Chiu

Associate Professor

 https://orcid.org/0000-0001-9952-4055
  • 500 Citations
  • 12 h-Index
20012021

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • Ph.D. (Pharmaceutics), School of Pharmacy, The Ohio State University, USA

Research Interests

  • Delivery of gene/siRNA/antisense agents by nanoparticles or liposomes
  • Targeted drug/gene/antisense delivery systems
  • Nanoparticle design and synthesis
  • Development of novel biomaterials for drug/gene/antisense delivery

Fingerprint Dive into the research topics where Shih-Jiuan Chiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

開發多功能奈米載體用於三陰性乳癌之化療藥物之遞送

Chiu, S.

8/1/19 → 7/31/20

Project: A - Government Institution › b - Ministry of Science and Technology

邱士娟-2019年度「計畫績效獎」

Chiu, S.

8/1/19 → 7/31/21

Project: B - Project of TMU › h - Other (Funded by TMU)

Multifunctional Nanoparticles for Cancer Therapy

Chiu, S.

8/1/15 → 7/31/16

Project: A - Government Institution › b - Ministry of Science and Technology

利用人類血清白蛋白作為反譯寡核?酸及化療藥物載體之研究

Chiu, S.

8/1/13 → 7/31/14

Project: B - Project of TMU › h - Other (Funded by TMU)

Simultaneous Delivery of an Antisense Oligonucleotide and a Chemotherapeutic Agent by a Her2-Targeted Liposomal System

Chiu, S.

8/1/12 → 7/31/13

Project: A - Government Institution › b - Ministry of Science and Technology

Research Output

  • 500 Citations
  • 12 h-Index
  • 28 Article
  • 1 Chapter
  • 1 Comment/debate

Author Correction: FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism (Scientific Reports, (2017), 7, 1, (5600), 10.1038/s41598-017-06047-9)

Bai, L. Y., Chiu, C. F., Chiu, S. J., Chu, P. C. & Weng, J. R., Dec 1 2020, In : Scientific Reports. 10, 1, 3322.

Research output: Contribution to journal › Comment/debate

Open Access

Divaricoside Exerts Antitumor Effects, in Part, by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells

Weng, J. R., Bai, L. Y., Chiu, S. J., Chiu, C. F., Lin, W. Y., Hu, J. L. & Shieh, T. M., Jan 1 2019, In : Computational and Structural Biotechnology Journal. 17, p. 151-159 9 p.

Research output: Contribution to journal › Article

    • 2 Citations (Scopus)

    A 5' AMP-Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral Squamous Cell Carcinoma

    Weng, J. R., Dokla, E. M. E., Bai, L. Y., Chen, C. S., Chiu, S. J. & Shieh, T. M., Jan 1 2018, (Accepted/In press) In : Basic and Clinical Pharmacology and Toxicology.

    Research output: Contribution to journal › Article

    • 3 Citations (Scopus)

    Formation of organosilica nanoparticles with dual functional groups and simultaneous payload entrapment

    Su, Y. L., Lin, C. Y., Chiu, S. J. & Hu, T. M., May 19 2018, In : Journal of Microencapsulation. 35, 4, p. 381-391 11 p.

    Research output: Contribution to journal › Article

    • 1 Citation (Scopus)

    FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism

    Bai, L. Y., Chiu, C. F., Chiu, S. J., Chu, P. C. & Weng, J. R., Dec 1 2017, In : Scientific Reports. 7, 1, 5600.

    Research output: Contribution to journal › Article

    • 15 Citations (Scopus)